SCHEMBL1629

SCHEMBL1629

COC(=O)C(C)CNCc1ccc(-c2ccccc2C#N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.45
WDR5 P61964 1/20 0.45
MME P08473 1/20 0.44
FFAR1 O14842 1/20 0.44
AKR1B1 P15121 1/20 0.44
ESR2 Q92731 1/20 0.43
PTPN1 P18031 1/20 0.42
OPRM1 P35372 2/20 0.41
OPRK1 P41145 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
ITGB1 P05556 1/20 0.41
ITGA4 P13612 1/20 0.41
ADAM17 P78536 1/20 0.41
KCNH2 Q12809 1/20 0.39
BDKRB1 P46663 2/20 0.39
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
BRS3 P32247 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2132 0.83 MYC (0.47) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL2870 0.83 MYC (0.47) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL2687 0.82 MYC (0.45) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL2432 0.81 MYC (0.45) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL8065614 0.81 MYC (0.45) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL2174 0.81 MYC (0.45) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL2208 0.81 MYC (0.48) MYCWDR5MMEFFAR1AKR1B1
Hydrochloric Acid SCHEMBL15663201 0.81 MYC (0.45) MYCWDR5MMEFFAR1AKR1B1
Hydrochloric Acid SCHEMBL3526296 0.81 MYC (0.45) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL2693 0.79 ITGB1 (0.46) MYCWDR5MMEFFAR1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965592-A HYPOTENSIVE AGENTS NOVARTIS CORPORATION (US) 1999-10-12 US disclosed
US-5399578-A Hypotensive; valsartan; high blood pressure and cardiac insufficiency CIBA-GEIGY CORP (US) 1995-03-21 US disclosed